Byatt J C, Collier R J
Animal Sciences Division, Monsanto Company, St. Louis, Missouri 63198, USA.
Proc Soc Exp Biol Med. 1995 Oct;210(1):20-4. doi: 10.3181/00379727-210-43919.
Bovine liver growth hormone receptors bind both bovine growth hormone (bGH) and bovine placental lactogen (bPL) with high affinity (Kd = 1.4 x 10(-11) M and 3.0 x 10(-11) M, respectively). By contrast, the uterine endometrium of pregnant cattle has high-affinity (Kd = 8.0 x 10(-11) M) binding sites for bPL but, displays negligible binding of bGH. A polyclonal antiserum raised against the extracellular domain of the bGH receptor, was used to determine if there was antigenic similarity between the liver bGH receptor and the endometrial bPL binding site(s). On Western blots, this antiserum displayed cross-reactivity with a 180,000-mol wt protein (nonreducing conditions) in detergent-solubilized extracts of microsomal membranes from both tissues. However, different detergents (Triton X-100 for endometrium and 3-[(3-cholamidopropyl)dimethylammonio]-1-propane-sulfonate [CHAPS] for liver) were required to solubilize the cross-reacting protein in the two tissues. The purified immunoglobulin fraction from this same antiserum also blocked binding of [125I]bPL to microsomal membrane preparations from both liver and endometrium. These results indicate that the endometrial binding site for bPL is antigenically similar to the bGH receptor and raise the possibility that it may be a modified GH receptor.
牛肝脏生长激素受体能以高亲和力结合牛生长激素(bGH)和牛胎盘催乳素(bPL)(解离常数Kd分别为1.4×10⁻¹¹ M和3.0×10⁻¹¹ M)。相比之下,怀孕母牛的子宫内膜有高亲和力(Kd = 8.0×10⁻¹¹ M)的bPL结合位点,但对bGH的结合可忽略不计。用针对bGH受体细胞外结构域产生的多克隆抗血清来确定肝脏bGH受体与子宫内膜bPL结合位点之间是否存在抗原相似性。在蛋白质免疫印迹法中,该抗血清与来自两种组织的微粒体膜去污剂溶解提取物中的一种180,000道尔顿分子量的蛋白质(非还原条件下)呈现交叉反应。然而,溶解两种组织中交叉反应蛋白需要不同的去污剂(子宫内膜用Triton X - 100,肝脏用3 - [(3 - 胆酰胺丙基)二甲基铵基]-1 - 丙烷磺酸盐[CHAPS])。来自同一抗血清的纯化免疫球蛋白组分也能阻断[¹²⁵I]bPL与来自肝脏和子宫内膜的微粒体膜制剂的结合。这些结果表明,子宫内膜的bPL结合位点在抗原性上与bGH受体相似,并增加了其可能是一种修饰的GH受体的可能性。